首页> 外文学位 >Molecular regulation of prostate biology and prostate cancer by signaling through the vitamin D receptor.
【24h】

Molecular regulation of prostate biology and prostate cancer by signaling through the vitamin D receptor.

机译:通过维生素D受体发出信号,对前列腺生物学和前列腺癌进行分子调控。

获取原文
获取原文并翻译 | 示例

摘要

High vitamin D status (serum 25-hydroxyvitamin D) and UV light exposure are associated with reduced risk of prostate cancer. The biologically active form of vitamin D, 1 alpha, 25-dihydroxyvitamin D (1,25(OH)2D) regulates expression of its target genes via its ligand activated transcription factor, the vitamin D receptor (VDR). To clarify the role of VDR signaling in the prevention of prostate cancer, we conducted three experiments. In the first experiment we used androgen depletion/repletion model in mice to test whether prostate epithelial cell (PEC) VDR level was important for the control of PEC proliferation and apoptosis. Analysis of the data revealed that loss of VDR signaling in mouse PEC increased proliferation by 97% (p0.05) and reduced apoptosis by 44% (p0.05) after androgen depletion and repletion. PEC VDR deletion also had a growth inhibitory effect on stromal cells during phases of active growth indicating a possible role of cell-cell communication in the regulation of prostate biology. In the second experiment we used APT121 mouse model of prostate cancer to test whether PEC VDR level was important for the control of prostate cancer. The data revealed that PEC VDR deletion increased the incidence of advanced lesions (i.e. adenocarcinomas) and reduced the incidence of less-advanced preneoplastic lesions in anterior prostate lobe. The number of foci and the area affected by adenocarcinoma was also significantly greater in animals with VDR knockout. These data suggest that increased progression of carcinogenesis occurs in the absence of VDR signaling in PEC. In the final experiment we used microarray analysis to identify potential vitamin D target genes and pathways affected by 1,25(OH)2D. Immortalized but non-tumorigenic prostate epithelial cells, (RWPE1), were treated with 1,25(OH)2D or vehicle for 6, 24, or 48 h and the transcript profile was assessed. Many transcript level changes were observed at each time point at a 5% false detection rate. Over 260 transcripts were regulated by 1,25(OH) 2D at all time points (79% up) and are considered potential direct vitamin D target genes that may modulate prostate carcinogenesis. Several of these were identified as direct targets of 1,25(OH)2D by using ChIP assay. Functional analysis of the microarray data revealed modulation of several functionally distinct pathways by 1,25(OH)2D, i.e. suppression of pro-proliferative and WNT signaling, suppression of pro-angiogenic VEGF signaling, suppression of pro-inflammatory cytokine signaling pathways, up-regulation of transcripts involved in the protection of cells from oxidative stress or DNA damage. This data demonstrated that VDR signaling is critical for anticancer effects of vitamin D. 1,25(OH)2D can suppress growth of normal prostate epithelial cells via multiple mechanism and initiate mechanisms preventing carcinogenic changes.
机译:高维生素D状态(血清25-羟基维生素D)和紫外线暴露可降低前列腺癌的风险。维生素D的生物活性形式1α,25-二羟基维生素D(1,25(OH)2D)通过其配体激活的转录因子维生素D受体(VDR)调节其靶基因的表达。为了阐明VDR信号在预防前列腺癌中的作用,我们进行了三个实验。在第一个实验中,我们在小鼠中使用雄激素耗竭/耗竭模型来测试前列腺上皮细胞(PEC)VDR水平对于控制PEC增殖和凋亡是否重要。数据分析显示,在雄激素消耗和补充后,小鼠PEC中VDR信号的丢失使增殖增加了97%(p <0.05),并使凋亡减少了44%(p <0.05)。 PEC VDR缺失在活跃生长阶段也对基质细胞具有生长抑制作用,表明细胞间通讯在调节前列腺生物学中可能发挥作用。在第二个实验中,我们使用前列腺癌的APT121小鼠模型来测试PEC VDR水平对于控制前列腺癌是否重要。数据显示,PEC VDR缺失增加了前列腺前叶中晚期病变(即腺癌)的发生率,并减少了晚期肿瘤前病变的发生率。在VDR基因敲除的动物中,病灶的数目和受腺癌影响的区域也显着增加。这些数据表明,PEC中不存在VDR信号传导时会发生癌变进程。在最后的实验中,我们使用微阵列分析来确定潜在的维生素D目标基因和受1,25(OH)2D影响的途径。用1,25(OH)2D或赋形剂处理永生化但非致瘤性的前列腺上皮细胞(RWPE1)6、24或48 h,并评估转录本谱。在每个时间点以5%的误检率观察到许多转录物水平的变化。 1,2,25(OH)2D在所有时间点都对260多个转录本进行了调节(上升了79%),被认为是潜在的直接维生素D靶基因,可调节前列腺癌的发生。通过ChIP分析,其中几个被确定为1,25(OH)2D的直接靶标。对微阵列数据的功能分析表明,1,2,5(OH)2D调节了几个功能上不同的途径,即抑制增殖和WNT信号传导,抑制促血管生成VEGF信号传导,抑制促炎性细胞因子信号传导途径, -调节转录物参与保护细胞免受氧化应激或DNA损伤。该数据表明,VDR信号对于维生素D的抗癌作用至关重要。1,25(OH)2D可通过多种机制抑制正常前列腺上皮细胞的生长,并启动防止致癌性变化的机制。

著录项

  • 作者

    Kovalenko, Pavlo L.;

  • 作者单位

    Purdue University.;

  • 授予单位 Purdue University.;
  • 学科 Biology Molecular.Health Sciences Oncology.Health Sciences Nutrition.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 232 p.
  • 总页数 232
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号